30.44
0.43%
-0.13
Castle Biosciences Inc (CSTL) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
10.37%
72.97
|
66.12 | 61.49 | 50.14 | 42.04 |
Cost Of Revenue |
11.84%
13.89
|
12.42 | 11.32 | 11.06 | 10.18 |
Gross Profit |
10.02%
59.08
|
53.70 | 50.17 | 39.08 | 31.86 |
Operating Expenses
|
8.75%
64.55
|
59.35 | 59.81 | 60.24 | 63.38 |
Interest Income/Expense |
600.00%
0.014
|
0.002 | 0.002 | 0.003 | 0.004 |
Benefits Costs and Expenses |
-
|
- | - | - | - |
Costs And Expenses |
9.29%
78.44
|
71.78 | 71.13 | 71.30 | 73.56 |
Operating Income/Loss |
3.31%
-5.471
|
-5.658 | -9.64 | -21.16 | -31.52 |
Income/Loss From Continuing Operations Before Tax |
10.37%
72.97
|
66.12 | 61.49 | -18.78 | -29.20 |
Income Tax Expense/Benefit, Deferred |
100.00%
-
|
-0.236 | - | - | 0.013 |
Income Tax Expense/Benefit |
15.38%
0.045
|
0.039 | 0.032 | 0.016 | 0.014 |
Income/Loss From Continuing Operations After Tax |
1.78%
-2.534
|
-2.58 | -6.905 | -18.78 | -29.20 |
Net Income/Loss
|
1.78%
-2.534
|
-2.58 | -6.905 | -18.78 | -29.20 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
35,595%
27.48
|
0.077 | 26.83 | 26.73 | 26.61 |
Diluted Average Shares |
35,595%
27.48
|
0.077 | 26.83 | 26.73 | 26.61 |
Basic Earnings Per Share |
0.00%
-0.09
|
-0.09 | -0.26 | -0.70 | -1.10 |
Diluted Earnings Per Share |
0.00%
-0.09
|
-0.09 | -0.26 | -0.70 | -1.10 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):